Spectral Medical Provides January Tigris Trial Update

Spectral Medical Inc. provided an update on the Company's Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated...

Related Keywords

Texas ,United States , ,Spectral Medical Inc ,Company Tigris ,Spectral Medical ,Polymyxinb Hemoperfusion ,January Closing ,Interim Enrollment ,Texas Health Sciences Center ,